# NSI-189 in Angelman syndrome mice: cognition and motor

Source: https://pepvault.app/research/nsi-189-liu-2019

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [NSI-189](https://pepvault.app/research#nsi-189)

Animal study · mice

# NSI-189 reversed cognitive and motor deficits in Angelman mice

Checked against the paper November 2026 Animal study [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

This adds early mouse evidence that NSI-189 may be worth studying for Angelman syndrome, but it is not a human result.

- **Kind:** Animal study
- **Studied in:** Mice
- **Published:** 2019
- **Journal:** Neuropharmacology

## What they tested

The team tested whether NSI-189 could improve brain signaling and reverse cognitive and motor problems in a mouse model of Angelman syndrome.

## How the study was done

A preclinical study in mice. Hippocampal slices from normal mice and Angelman syndrome model mice were treated with NSI-189 in the lab, and Angelman model mice and normal mice also got a short course of daily NSI-189 injections.

<!--promo-->

PepVault for iPhone

## Taking NSI-189? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

In hippocampal slices from normal mice, NSI-189 raised LTP (long-term potentiation, a lasting strengthening of signals between nerve cells), and the effect grew with dose and time. It also raised LTP in slices from Angelman model mice. In Angelman model mice, a short course of daily injections reversed impairments in cognitive and motor function, and normal mice performed slightly better. These effects went along with activation of the TrkB and Akt pathways.

## What it doesn’t show

This was work in mice and mouse brain tissue, not people with Angelman syndrome. The treatment course was short, so it does not show longer-term effects or safety.

## The paper

Liu et al. Enhancement of synaptic plasticity and reversal of impairments in motor and cognitive functions in a mouse model of Angelman Syndrome by a small neurogenic molecule, NSI-189. Neuropharmacology. 2019.

- [PubMed (PMID 30408487)](https://pubmed.ncbi.nlm.nih.gov/30408487/)
- [The paper (DOI 10.1016/j.neuropharm.2018.10.038)](https://doi.org/10.1016/j.neuropharm.2018.10.038)

## The compound

- [NSI-189: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/nsi-189)
- [NSI-189 dose guide](https://pepvault.app/lab/dosage/nsi-189)

## With this study

### NSI-189

- [NSI-189: the full reference](https://pepvault.app/peptides/nsi-189)
- [NSI-189 dose guide](https://pepvault.app/lab/dosage/nsi-189)

### Studies

- [NSI-189 80 mg beat placebo in moderate, not severe, depression](https://pepvault.app/research/nsi-189-johe-2020)
- [NSI-189 eased nerve damage and memory problems in diabetic rats](https://pepvault.app/research/nsi-189-jolivalt-2022)
- [NSI-189 protected nerves and memory in diabetic mice](https://pepvault.app/research/nsi-189-jolivalt-2019)
- [All 5 studies](https://pepvault.app/research#nsi-189)

### Compared with

- [Semax vs NSI-189](https://pepvault.app/peptides/compare/semax-vs-nsi-189)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

## More studies on NSI-189

- [NSI-189 80 mg beat placebo in moderate, not severe, depression](https://pepvault.app/research/nsi-189-johe-2020) Randomized trial · people · 2020
- [NSI-189 eased nerve damage and memory problems in diabetic rats](https://pepvault.app/research/nsi-189-jolivalt-2022) Animal study · rats · 2022
- [NSI-189 protected nerves and memory in diabetic mice](https://pepvault.app/research/nsi-189-jolivalt-2019) Animal study · mice · 2019
- [NSI-189 eased motor and neurological deficits after stroke in rats](https://pepvault.app/research/nsi-189-tajiri-2017) Animal study · rats · 2017
- [Every study on NSI-189](https://pepvault.app/research#nsi-189)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking NSI-189? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking NSI-189? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### NSI-189

- [NSI-189: the full reference](https://pepvault.app/peptides/nsi-189)
- [NSI-189 dose guide](https://pepvault.app/lab/dosage/nsi-189)

### Studies

- [NSI-189 80 mg beat placebo in moderate, not severe, depression](https://pepvault.app/research/nsi-189-johe-2020)
- [NSI-189 eased nerve damage and memory problems in diabetic rats](https://pepvault.app/research/nsi-189-jolivalt-2022)
- [NSI-189 protected nerves and memory in diabetic mice](https://pepvault.app/research/nsi-189-jolivalt-2019)
- [All 5 studies](https://pepvault.app/research#nsi-189)

### Compared with

- [Semax vs NSI-189](https://pepvault.app/peptides/compare/semax-vs-nsi-189)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

<!--promo-->

PepVault for iPhone

## Taking NSI-189? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on NSI-189](https://pepvault.app/research#nsi-189)

## The library

- [NSI-189](https://pepvault.app/peptides/nsi-189)
- [NSI-189 dose guide](https://pepvault.app/lab/dosage/nsi-189)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
